A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Lumateperone for the Treatment of Major Depressive Episodes (MDEs) Associated With Bipolar I or Bipolar II Disorder (Bipolar Depression) in Pediatric Patients Aged 10 to 17 Years
Status: Recruiting
Location: See all (59) locations...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 3
SUMMARY
This is a multicenter, randomized, double-blind, placebo-controlled study in pediatric patients who are experiencing major depressive episodes (MDEs) associated with a primary diagnosis of bipolar I or bipolar II disorder as confirmed by Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL), according to criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM 5).
Eligibility
Participation Requirements
Sex: All
Minimum Age: 10
Maximum Age: 17
Healthy Volunteers: f
View:
• Able to provide consent as follows:
‣ The Legally Authorized Representative (LAR) must provide written, informed consent.
⁃ The patient must provide written assent;
• Male or female patients 10 to 17 years of age, inclusive;
• Have a Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition Text Revision (DSM-5-TR) primary diagnosis of bipolar I or bipolar II disorder with a current MDE without psychosis as confirmed by Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL);
• Subject has a lifetime history of at least one manic or hypomanic episode.
• Subject's current major depressive episode is ≥ 4 weeks and less than 12 months in duration;
• CDRS-R total score ≥ 45 with ≥ 5 on Item 11 (depressed feelings) at Screening and Baseline;
• Young Mania Rating Scale (YMRS) score ≤ 15 (with YMRS Item 1 \[elevated mood\] score ≤ 2) at Screening and Baseline.
Locations
United States
Alabama
Clinical Site
RECRUITING
Dothan
Arkansas
Clinical Site
RECRUITING
Little Rock
California
Clinical Site
RECRUITING
Anaheim
Clinical Site
RECRUITING
Redlands
Clinical Site
NOT_YET_RECRUITING
Sacramento
Clinical Site
RECRUITING
San Diego
Clinical Site
RECRUITING
West Covina
Colorado
Clinical Site
RECRUITING
Colorado Springs
Florida
Clinical Site
NOT_YET_RECRUITING
Gainesville
Clinical Site
RECRUITING
Hialeah
Clinical Site
RECRUITING
Homestead
Clinical Site
RECRUITING
Miami
Clinical Site
RECRUITING
Miami
Clinical Site
RECRUITING
Miami
Clinical Site
RECRUITING
Miami
Clinical Site
RECRUITING
Miami
Clinical Site
RECRUITING
Miami
Clinical Site
RECRUITING
Miami
Clinical Site
RECRUITING
Miami
Clinical Site
RECRUITING
Miami
Clinical Site
RECRUITING
Miami Gardens
Clinical Site
RECRUITING
Miami Lakes
Clinical Site
RECRUITING
Miami Lakes
Clinical Site
RECRUITING
Miami Springs
Clinical Site
RECRUITING
Orlando
Clinical Site
RECRUITING
West Palm Beach
Georgia
Clinical Site
RECRUITING
Atlanta
Clinical Site
RECRUITING
Decatur
Clinical Site
RECRUITING
Lawrenceville
Clinical Site
RECRUITING
Savannah
Illinois
Clinical Site
NOT_YET_RECRUITING
Chicago
Indiana
Clinical Site
RECRUITING
Indianapolis
Maryland
Clinical Site
NOT_YET_RECRUITING
Baltimore
Michigan
Clinical Site
RECRUITING
Bloomfield Hills
Missouri
Clinical Site
RECRUITING
Saint Charles
North Carolina
Clinical Site
NOT_YET_RECRUITING
Kinston
Nebraska
Clinical Site
RECRUITING
Lincoln
Ohio
Clinical Site
RECRUITING
Avon Lake
Clinical Site
RECRUITING
Cincinnati
Clinical Site
RECRUITING
Garfield
Clinical Site
RECRUITING
Westlake
Oklahoma
Clinical Site
RECRUITING
Oklahoma City
Clinical Site
RECRUITING
Oklahoma City
Texas
Clinical Site
RECRUITING
Austin
Clinical Site
RECRUITING
Flower Mound
Clinical Site
NOT_YET_RECRUITING
Frisco
Clinical Site
RECRUITING
Houston
Clinical Site
RECRUITING
Houston
Clinical Site
RECRUITING
Richmond
Virginia
Clinical Site
RECRUITING
Richmond
Washington
Clinical Site
RECRUITING
Bellevue
Clinical Site
RECRUITING
Everett
Other Locations
India
Clinical Site
RECRUITING
Ahmedabad
Clinical Site
RECRUITING
Aurangabad
Clinical Site
RECRUITING
Nashik
Clinical Site
RECRUITING
Varanasi
Serbia
Clinical Site
RECRUITING
Belgrade
Clinical Site
RECRUITING
Niš
Clinical Site
RECRUITING
Novi Sad
Contact Information
Primary
ITI Clinical Trials
ITCIClinicalTrials@itci-inc.com
646 440-9333
Time Frame
Start Date:2024-05-13
Estimated Completion Date:2027-05
Participants
Target number of participants:384
Treatments
Experimental: Lumateperone
Lumateperone 42 mg for patient ages 13-17 years and Lumateperone 21 mg for patient ages 10-12 years.